Clinical trials test the safety and benefits of new treatments as well as new combinations or new doses of standard treatments. They can also study….
Susan G. Komen® North Texas (based in Plano, Texas) and Susan G. Komen® West Texas (based in Amarillo and Lubbock) announced today that they are….
From May 1-3, Susan G. Komen Headquarters hosted the 2019 Advocacy Summit in Washington, D.C. to prepare approximately 300 Affiliate staff, Board members, volunteers, survivors,….
ABOUT THE GRANT-MAKING PROCESS Grant-making is the primary activity by which we invest in our community while ensuring quality, consistency, and transparency during the process. ….
Susan G. Komen is the voice for the more than 3.1 million breast cancer survivors living in the United States and those who love them,….
African American women are 40% more likely to die from breast cancer than white women, are often diagnosed at later stages when treatments are limited,….
SUSAN G. KOMEN ANNOUNCES NEARLY $26 MILLION INVESTMENT IN NEW RESEARCH TO FIND SOLUTIONS FOR AGGRESSIVE AND METASTATIC BREAST CANCERS, AND TO HELP COMMUNITIES MOST….
DALLAS – JULY 26, 2018 – Susan G. Komen®, the world’s largest nonprofit funder of breast cancer research, today hailed work led by Komen researcher….
On Friday, March 2nd, Susan G. Komen North Texas hosted its very first Scholar Breakfast, an event that brings in a Komen Scholar – a….
Keydra was not your average 28-year-old. She had just opened a business, and was in the middle of a very busy time in her life….